These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 23533219
21. Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice. Xu JL, Li LY, Wang YQ, Li YQ, Shan M, Sun SZ, Yu Y, Wang B. J Lipid Res; 2018 Jan; 59(1):35-47. PubMed ID: 29113994 [Abstract] [Full Text] [Related]
22. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. Liu LF, Purushotham A, Wendel AA, Belury MA. Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064 [Abstract] [Full Text] [Related]
23. Expression patterns of activin, inhibin and follistatin variants in the adult male mouse reproductive tract suggest important roles in the epididymis and vas deferens. Winnall WR, Wu H, Sarraj MA, Rogers PA, de Kretser DM, Girling JE, Hedger MP. Reprod Fertil Dev; 2013 Jun; 25(3):570-80. PubMed ID: 23164397 [Abstract] [Full Text] [Related]
24. Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice. Guo X, Li H, Xu H, Halim V, Zhang W, Wang H, Ong KT, Woo SL, Walzem RL, Mashek DG, Dong H, Lu F, Wei L, Huo Y, Wu C. PLoS One; 2012 Jun; 7(6):e39286. PubMed ID: 22768070 [Abstract] [Full Text] [Related]
26. Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis. Jiang T, Zhang Y, Bai M, Li P, Wang W, Chen M, Ma Z, Zeng S, Zhou H, Jiang H. Toxicol Lett; 2019 Nov 29; 316():183-193. PubMed ID: 31437515 [Abstract] [Full Text] [Related]
27. Hepatic steatosis by dietary-conjugated linoleic acid is accompanied by accumulation of diacylglycerol and increased membrane-associated protein kinase C ε in mice. Stout MB, Liu LF, Belury MA. Mol Nutr Food Res; 2011 Jul 29; 55(7):1010-7. PubMed ID: 21480517 [Abstract] [Full Text] [Related]
28. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance. Wueest S, Item F, Lucchini FC, Challa TD, Müller W, Blüher M, Konrad D. Diabetes; 2016 Jan 29; 65(1):140-8. PubMed ID: 26384383 [Abstract] [Full Text] [Related]
29. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet. Muraoka T, Aoki K, Iwasaki T, Shinoda K, Nakamura A, Aburatani H, Mori S, Tokuyama K, Kubota N, Kadowaki T, Terauchi Y. Metabolism; 2011 May 29; 60(5):617-28. PubMed ID: 20673929 [Abstract] [Full Text] [Related]
30. Farrerol alleviates insulin resistance and hepatic steatosis of metabolic associated fatty liver disease by targeting PTPN1. Gao J, Cang X, Liu L, Lin J, Zhu S, Liu L, Liu X, Zhu J, Xu C. J Cell Mol Med; 2024 Sep 29; 28(18):e70096. PubMed ID: 39289804 [Abstract] [Full Text] [Related]
31. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Wada T, Kenmochi H, Miyashita Y, Sasaki M, Ojima M, Sasahara M, Koya D, Tsuneki H, Sasaoka T. Endocrinology; 2010 May 29; 151(5):2040-9. PubMed ID: 20211973 [Abstract] [Full Text] [Related]
32. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, Wakkach A, Dahman M, Tordjman J, Clément K, McQuaid SE, Frayn KN, Huet PM, Gugenheim J, Lotersztajn S, Le Marchand-Brustel Y, Tran A, Gual P. Diabetes; 2009 Jan 29; 58(1):125-33. PubMed ID: 18952835 [Abstract] [Full Text] [Related]
33. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease. Lin Y, Ding D, Huang Q, Liu Q, Lu H, Lu Y, Chi Y, Sun X, Ye G, Zhu H, Wei J, Dong S. Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep 29; 1862(9):869-882. PubMed ID: 28483554 [Abstract] [Full Text] [Related]
34. The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism. Wang Y, Zhang Y, Qian H, Lu J, Zhang Z, Min X, Lang M, Yang H, Wang N, Zhang P. PLoS One; 2013 Sep 29; 8(8):e72315. PubMed ID: 23951308 [Abstract] [Full Text] [Related]
35. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. Benhamed F, Denechaud PD, Lemoine M, Robichon C, Moldes M, Bertrand-Michel J, Ratziu V, Serfaty L, Housset C, Capeau J, Girard J, Guillou H, Postic C. J Clin Invest; 2012 Jun 29; 122(6):2176-94. PubMed ID: 22546860 [Abstract] [Full Text] [Related]
36. Liver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosis. Liu Y, Zhou D, Zhang F, Tu Y, Xia Y, Wang H, Zhou B, Zhang Y, Wu J, Gao X, He Z, Zhai Q. J Lipid Res; 2012 Mar 29; 53(3):358-367. PubMed ID: 22231784 [Abstract] [Full Text] [Related]
37. Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance. Williams AS, Kang L, Zheng J, Grueter C, Bracy DP, James FD, Pozzi A, Wasserman DH. J Biol Chem; 2015 Mar 06; 290(10):6546-57. PubMed ID: 25593319 [Abstract] [Full Text] [Related]
38. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors. Cortés VA, Cautivo KM, Rong S, Garg A, Horton JD, Agarwal AK. J Lipid Res; 2014 Feb 06; 55(2):276-88. PubMed ID: 24293639 [Abstract] [Full Text] [Related]
39. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance. Cantley JL, Yoshimura T, Camporez JP, Zhang D, Jornayvaz FR, Kumashiro N, Guebre-Egziabher F, Jurczak MJ, Kahn M, Guigni BA, Serr J, Hankin J, Murphy RC, Cline GW, Bhanot S, Manchem VP, Brown JM, Samuel VT, Shulman GI. Proc Natl Acad Sci U S A; 2013 Jan 29; 110(5):1869-74. PubMed ID: 23302688 [Abstract] [Full Text] [Related]
40. Activin Enhances α- to β-Cell Transdifferentiation as a Source For β-Cells In Male FSTL3 Knockout Mice. Brown ML, Andrzejewski D, Burnside A, Schneyer AL. Endocrinology; 2016 Mar 29; 157(3):1043-54. PubMed ID: 26727106 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]